Gleason Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Gleason Group's AMGN Position: Q2 2026 in Review
Gleason Group increased its Amgen (AMGN) stake by 6% in Q2 2026, buying an estimated $7.53K and bringing the position to 389 shares worth $141K. The position accounts for 0.01% of the portfolio, ranked #86.
Gleason Group first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Gleason Group held 389 shares of Amgen worth $141K as of Q2 2026.
- Gleason Group bought 22 Amgen shares in Q2 2026, an estimated $7.53K.
- Amgen made up 0.01% of Gleason Group's portfolio in Q2 2026, its #86 holding.
- Gleason Group first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Gleason Group's 13F filing for Q2 2026, filed 13 Jul 2026.